The AUA has released its first clinical guideline on the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).
The AUA has released its first clinical guideline on the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).
The new guideline is designed to present a clinical strategy for physicians, and the guideline panel notes that the most effective approach for a specific case should be determined by individual patients and their clinician.
Panel experts recommend the following assessments for both women and men:
The panel outlines the following key clinical principles for first-line treatment:
"IC/BPS affects a significant number of patients whose quality of life is severely diminished by this complicated, frustrating condition," said Philip M. Hanno, MD, MPH, of the University of Pennsylvania, Philadelphia, who chaired the multidisciplinary panel that developed the guideline. "This population has historically been both under-recognized and underserved, and it is our hope that this guideline provides physicians with a much-needed roadmap to help treat these patients."
A complete executive summary of the guideline will be published in an upcoming issue of the Journal of Urology, and a Webinar about the guideline will also be made available online at www.AUAnet.org. Look for a more detailed report on the guideline in an upcoming issue of Urology Times.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.